Ally Bridge Group (NY)
$78M 13F equity value
31 Holdings
Quarter ended June 30, 2026
The latest 13F on file for Ally Bridge Group (NY) covers the quarter ended June 30, 2026. Institutional managers report holdings quarterly to the SEC, so each filing is a snapshot of positions held on that date.
Top Holdings
| Ticker | Company | Shares | Value | Weight |
|---|---|---|---|---|
| NERV | MINERVA NEUROSCIENCES INC | 2,175,802 | $12M | 15.6% |
| PMN | PROMIS NEUROSCIENCES INC | 620,319 | $8M | 10.5% |
| TRAX | FIRST TRACKS BIOTHERAPEUTICS | 284,287 | $6M | 7.4% |
| AXSM | AXSOME THERAPEUTICS INC | 16,493 | $4M | 5.2% |
| ASMB | ASSEMBLY BIOSCIENCES INC | 140,000 | $4M | 5.0% |
| WHWK | WHITEHAWK THERAPEUTICS INC | 817,939 | $4M | 4.8% |
| EWTX | EDGEWISE THERAPEUTICS INC | 83,300 | $3M | 4.4% |
| CLYM | CLIMB BIO INC | 249,172 | $3M | 4.2% |
| KURA | KURA ONCOLOGY INC | 290,000 | $3M | 4.1% |
| CTMX | CYTOMX THERAPEUTICS INC. | 775,000 | $3M | 3.7% |
Track Ally Bridge Group (NY)'s 13F portfolio: $78M in reported holdings, 31 positions. Top holdings and quarterly changes on SentiSense.
This page is powered by the SentiSense API: GET /api/v1/institutional/institution/{slugOrCik}